Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07291375

Role of Amlodipine in Reduction of CIN

The Effect of Low Dose Oral Amlodipine in Renal Protection From Contrast Induced Nephropathy in Diabetic Patients in Intensive Care Unit

Status
Not Yet Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Minia University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit

Conditions

Interventions

TypeNameDescription
DRUGCalcium channel blockeramlodipine group will receive low dose oral amlodipine ( 5 mg ) before iv contrast and every 12 hour for 48 hour
OTHERHydrationbefore the procedure patients will recieve iv bolus of 250 ml saline followed by continous infusion of 100 ml/h of normal saline

Timeline

Start date
2025-12-20
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2025-12-18
Last updated
2025-12-18

Source: ClinicalTrials.gov record NCT07291375. Inclusion in this directory is not an endorsement.